ACC/AHA release new guidelines for HCM

Posted by: drchasrani on: June 14, 2012

It has been observed that there are many patients of hyertrophic cardiomyopathy than thought. Hence a new guide line is suggested for treating them.                                                    Team@CMHF

 With nearly 600,000 people affected by hypertrophic cardiomyopathy (HCM), a disease that goes largely undetected and can decrease life expectancy, the American Heart Association (AHA) and American College of Cardiology Foundation (ACCF) put forth new guidelines about recommendations on how to detect, treat and manage patients with the genetic disease.

The authors said that controversy has also stemmed from which HCM patients should be placed with an implantable cardioverter defibrillator (ICD).

The following is recommended for Class I HCM patients: Genetic testing, Electrophysiology, Stress Testing, and Cardiac MRI.

On top of the aforementioned recommendations for HCM patients, the task force recommended beta-blocker drugs be used for the treatment of symptoms in HCM patients; however, they noted that caution should be applied in patients with sinus bradycardia or severe conduction disease.

“Although much progress has been made in understanding HCM, more research is needed to present more opportunities to improve patient outcomes,” the task force concluded.





Leave a Reply

Your email address will not be published. Required fields are marked *


CMHF Accredited by Maharashtra Medical Council

Subscribe to our Posts

Enter your email address:

  • drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
  • rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
  • nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards

Calculate Your Body Mass Index

Check your Body Mass Index »

    Pear - 55 kcal in 100g
    Pear - 55 kcal in 100g
    by Noni